qiming venture partners

Thanks to the track record of its founding team, INCE Capital has raised more than $350 million for the hard cap of its debut fund.

In the second part of our China Awards series, FinanceAsia reveals the rationale behind the decisions for this year's non-bank service provider winners.

Insilico Medicine wants to speed up the process of drug development with its AI technology - and it is already doing so with the help of WuXi AppTech.

The e-commerce platform for second-hand fashion products has raised $20 million to help it sell high-end luxury on the cheap.

Many view medical-related investments as defensive in times of economic instability, but William Hu from Qiming Venture Partners reckons that it can be profitable if you are on the right track.